Total Payments
$60,853
2024 Payments
$28,080
Companies
11
Transactions
107
Medicare Patients
8,328
Medicare Billing
$616,426
Payment Breakdown by Category
Other$49,321 (81.0%)
Travel$8,564 (14.1%)
Food & Beverage$2,969 (4.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $39,941 | 20 | 65.6% |
| Honoraria | $9,380 | 3 | 15.4% |
| Travel and Lodging | $8,564 | 30 | 14.1% |
| Food and Beverage | $2,969 | 54 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, plc | $58,386 | 77 | $0 (2024) |
| Abbott Laboratories | $1,633 | 13 | $0 (2024) |
| Boston Scientific Corporation | $449.06 | 4 | $0 (2024) |
| Braemar Manufacturing, LLC | $190.07 | 1 | $0 (2018) |
| Amgen Inc. | $51.47 | 3 | $0 (2018) |
| Edwards Lifesciences Corporation | $43.35 | 1 | $0 (2018) |
| Lantheus Medical Imaging, Inc. | $33.73 | 2 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $19.48 | 1 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $18.30 | 3 | $0 (2017) |
| Philips North America LLC | $18.00 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28,080 | 52 | Kiniksa Pharmaceuticals International, plc ($26,444) |
| 2023 | $26,025 | 31 | Kiniksa Pharmaceuticals, Ltd. ($26,006) |
| 2022 | $196.16 | 3 | Kiniksa Pharmaceuticals, Ltd. ($162.43) |
| 2021 | $5,900 | 8 | Kiniksa Pharmaceuticals, Ltd. ($5,773) |
| 2019 | $90.91 | 1 | Boston Scientific Corporation ($90.91) |
| 2018 | $508.88 | 7 | BOSTON SCIENTIFIC CORPORATION ($225.51) |
| 2017 | $52.76 | 5 | Amgen Inc. ($34.46) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $670.00 | General |
| Category: Rheumatology | ||||||
| 11/19/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Travel and Lodging | In-kind items and services | $316.98 | General |
| Category: Rheumatology | ||||||
| 11/19/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Travel and Lodging | In-kind items and services | $316.48 | General |
| Category: Rheumatology | ||||||
| 11/19/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Travel and Lodging | In-kind items and services | $314.07 | General |
| Category: Rheumatology | ||||||
| 11/19/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $91.88 | General |
| Category: Rheumatology | ||||||
| 11/19/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Travel and Lodging | In-kind items and services | $80.00 | General |
| Category: Rheumatology | ||||||
| 11/19/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Travel and Lodging | In-kind items and services | $80.00 | General |
| Category: Rheumatology | ||||||
| 11/13/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $670.00 | General |
| Category: Rheumatology | ||||||
| 10/18/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,030.00 | General |
| Category: Rheumatology | ||||||
| 10/18/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Travel and Lodging | Cash or cash equivalent | $138.75 | General |
| Category: Rheumatology | ||||||
| 10/18/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $47.16 | General |
| Category: Rheumatology | ||||||
| 10/15/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $670.00 | General |
| Category: Rheumatology | ||||||
| 09/19/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Not Applicable | ||||||
| 09/11/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Travel and Lodging | In-kind items and services | $855.90 | General |
| Category: Rheumatology | ||||||
| 09/11/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Travel and Lodging | In-kind items and services | $212.80 | General |
| Category: Rheumatology | ||||||
| 09/11/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $102.61 | General |
| Category: Rheumatology | ||||||
| 09/11/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Travel and Lodging | In-kind items and services | $80.00 | General |
| Category: Rheumatology | ||||||
| 09/07/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $132.64 | General |
| Category: General - Stents_IC | ||||||
| 09/03/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,345.00 | General |
| Category: Rheumatology | ||||||
| 09/03/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Travel and Lodging | Cash or cash equivalent | $20.10 | General |
| Category: Rheumatology | ||||||
| 08/27/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $670.00 | General |
| Category: Rheumatology | ||||||
| 08/01/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $100.97 | General |
| Category: Rheumatology | ||||||
| 08/01/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: Not Applicable | ||||||
| 07/12/2024 | Abbott Laboratories | — | Travel and Lodging | In-kind items and services | $186.74 | General |
| Category: Structural Heart | ||||||
| 07/02/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Structural Heart | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,869 | 2,262 | $721,868 | $130,523 |
| 2022 | 17 | 2,249 | 2,400 | $844,533 | $152,586 |
| 2021 | 17 | 2,228 | 2,526 | $1.0M | $177,611 |
| 2020 | 20 | 1,982 | 2,292 | $1.0M | $155,706 |
Total Patients
8,328
Total Services
9,480
Medicare Billing
$616,426
Procedure Codes
93
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 524 | 549 | $159,210 | $29,982 | 18.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 172 | 174 | $182,448 | $27,665 | 15.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 126 | 142 | $52,390 | $12,825 | 24.5% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 58 | 59 | $67,850 | $11,445 | 16.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 122 | 133 | $46,165 | $9,416 | 20.4% |
| Q9950 | Injection, sulfur hexafluoride lipid microspheres, per ml | Office | 2023 | 141 | 439 | $32,211 | $6,440 | 20.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 99 | $25,172 | $6,425 | 25.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $21,242 | $4,363 | 20.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 33 | $11,715 | $3,235 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 60 | 65 | $15,340 | $3,101 | 20.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 31 | 31 | $16,211 | $2,953 | 18.2% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 30 | 30 | $12,030 | $2,462 | 20.5% |
| 93355 | Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | Facility | 2023 | 12 | 12 | $9,936 | $2,192 | 22.1% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 33 | 33 | $10,244 | $2,071 | 20.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $8,944 | $1,594 | 17.8% |
| 76376 | 3d radiographic procedure | Office | 2023 | 51 | 51 | $19,401 | $1,089 | 5.6% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 30 | 34 | $4,454 | $695.98 | 15.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 86 | 92 | $3,036 | $582.03 | 19.2% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 15 | 15 | $2,278 | $501.90 | 22.0% |
| 76376 | 3d radiographic procedure | Facility | 2023 | 55 | 56 | $5,040 | $430.65 | 8.5% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 43 | 44 | $6,544 | $413.60 | 6.3% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 45 | 48 | $1,728 | $274.01 | 15.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 25 | 25 | $4,566 | $249.75 | 5.5% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 43 | 47 | $3,713 | $117.30 | 3.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 685 | 724 | $209,960 | $41,223 | 19.6% |
About Dr. Ajit Raisinghani, M.D
Dr. Ajit Raisinghani, M.D is a Cardiovascular Disease healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831292796.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ajit Raisinghani, M.D has received a total of $60,853 in payments from pharmaceutical and medical device companies, with $28,080 received in 2024. These payments were reported across 107 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($39,941).
As a Medicare-enrolled provider, Raisinghani has provided services to 8,328 Medicare beneficiaries, totaling 9,480 services with total Medicare billing of $616,426. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location San Diego, CA
- Active Since 09/06/2006
- Last Updated 07/09/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1831292796
Products in Payments
- Arcalyst (Drug) $46,341
- WATCHMAN (Device) $316.42
- Cardiac Monitoring Suite (Device) $190.07
- MitraClip System (Device) $126.22
- Repatha (Biological) $51.47
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $43.35
- DEFINITY (Drug) $33.73
- CardioMEMS HF System (Device) $22.10
- LifeVest (Device) $18.30
- (5044) MCOT (Device) $18.00
- PRALUENT ALIROCUMAB INJECTION (Biological) $10.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in San Diego
Jonathan Hsu, Md, MD
Cardiovascular Disease — Payments: $1.1M
Cardiovascular Disease $1.1M
Dr. Raghava Gollapudi, M.d, M.D
Cardiovascular Disease — Payments: $572,162
Cardiovascular Disease $572,162
Dr. Hirsch Mehta, Md, MD
Cardiovascular Disease — Payments: $527,825
Cardiovascular Disease $527,825
Dr. Barry Greenberg, M.d, M.D
Cardiovascular Disease — Payments: $463,770
Cardiovascular Disease $463,770
Dr. Mitul Patel, M.d, M.D
Cardiovascular Disease — Payments: $459,569
Cardiovascular Disease $459,569
Dr. Ulrika Birgersdotter-Green, Md, MD
Cardiovascular Disease — Payments: $430,713
Cardiovascular Disease $430,713